095700.KQ

Genexine, Inc. [095700.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

095700.KQ Stock Summary

Top 10 Correlated ETFs

095700.KQ


Top 10 Correlated Stocks

095700.KQ


In the News

095700.KQ Financial details

Company Rating
Buy
Market Cap
377.61B
Income
-66.87B
Revenue
4.43B
Book val./share
7156.17
Cash/share
1555.67
Dividend
-
Dividend %
-
Employees
98
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-3.8
Forward P/E
-0.35
PEG
12.32
P/S
56.63
P/B
1.26
P/C
5.81
P/FCF
-7.74
Quick Ratio
1.12
Current Ratio
1.54
Debt / Equity
0.23
LT Debt / Equity
0.08
-
-
EPS (TTM)
-1.67K
EPS next Y
-25497.3
EPS next Q
229
EPS this Y
-4.17%
EPS next Y
1425.96%
EPS next 5Y
1425.96%
EPS last 5Y
24.33%
Revenue last 5Y
-17.1%
Revenue Q/Q
316.43%
EPS Q/Q
-112.37%
-
-
-
-
SMA20
10.78%
SMA50
-5.96%
SMA100
16.02%
Inst Own
-
Inst Trans
-
ROA
-25%
ROE
-33%
ROC
-0.13%
Gross Margin
19%
Oper. Margin
-625%
Profit Margin
-1467%
Payout
-
Shs Outstand
41.45M
Shs Float
32.39M
-
-
-
-
Target Price
-
52W Range
7250.0-14640.0
52W High
-38.25%
52W Low
+24.69%
RSI
58
Rel Volume
0.55
Avg Volume
258.98K
Volume
141.23K
Perf Week
-2.16%
Perf Month
5.12%
Perf Quarter
2.26%
Perf Half Y
2.03%
-
-
-
-
Beta
0.906
-
-
Volatility
106.06%, 482.99%
Prev Close
-2.48%
Price
9040
Change
-0.44%

095700.KQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
380.71555.231.06K494.45109.36
Net income per share
-556.06825.49-1.38K-1.72K-1.65K
Operating cash flow per share
-1.4K-679.41-367.41-1.22K-922.6
Free cash flow per share
-1.57K-1.4K-2.01K-2.19K-1.1K
Cash per share
2.78K201.02801.26672.251.59K
Book value per share
10K16.04K14.92K8.46K7.33K
Tangible book value per share
9.85K15.94K14.99K8.54K7.29K
Share holders equity per share
10K16.04K14.92K8.46K7.33K
Interest debt per share
1.47K921.61.57K2.67K1.77K
Market cap
1427.38B3193.37B1555.7B465.75B418.13B
Enterprise value
1447.71B3215.31B1580.12B531.89B479.52B
P/E ratio
-86.46115.83-32.6-8.28-6.25
Price to sales ratio
126.28172.2142.2428.8694.46
POCF ratio
-34.34-140.73-122.06-11.7-11.2
PFCF ratio
-30.6-68.22-22.3-6.51-9.35
P/B Ratio
4.815.9631.691.41
PTB ratio
4.815.9631.691.41
EV to sales
128.08173.3942.932.96108.33
Enterprise value over EBITDA
-32.7-78.65-71.26-18.01-13
EV to operating cash flow
-34.82-141.7-123.98-13.36-12.84
EV to free cash flow
-31.03-68.69-22.65-7.43-10.72
Earnings yield
-0.010.01-0.03-0.12-0.16
Free cash flow yield
-0.03-0.01-0.04-0.15-0.11
Debt to equity
0.130.050.10.30.23
Debt to assets
0.110.050.080.220.18
Net debt to EBITDA
-0.46-0.54-1.1-2.24-1.66
Current ratio
4.230.510.970.661.69
Interest coverage
-10.17-11.45-11.17-10.34-10.03
Income quality
2.52-0.820.270.710.56
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.170.060.150.43
Research and developement to revenue
3.672.31.041.535.31
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
0.121.064.470.80.2
Capex to revenue
-0.45-1.3-1.55-1.97-1.67
Capex to depreciation
-2.16-8.66-17.28-6.52-1.47
Stock based compensation to revenue
0.120.190.080.20.67
Graham number
11.19K17.26K21.49K18.12K16.5K
ROIC
-6.16-0.08-0.04-0.08-0.15
Return on tangible assets
-0.050.05-0.08-0.15-0.18
Graham Net
150.2-1.41K-2.27K-2.1K-4.39
Working capital
73.18B-19.57B-1.88B-26.55B37.63B
Tangible asset value
292.31B532.47B519.99B278.85B294.89B
Net current asset value
34.55B-39.73B-56.32B-55.49B12.48B
Invested capital
0.130.050.10.30.23
Average receivables
07.51B7.25B9.87B16.24B
Average payables
04.28B000
Average inventory
0-21.48B2.83B9.6B7.92B
Days sales outstanding
169.74192.146.96339.171.44K
Days payables outstanding
543.810000
Days of inventory on hand
-2.64K-60.95340.88496.92164.93
Receivables turnover
2.151.97.771.080.25
Payables turnover
0.670000
Inventory turnover
-0.14-5.991.070.732.21
ROE
-0.060.05-0.09-0.2-0.23
Capex per share
-171.16-722.09-1.64K-973.62-182.29

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
70.6118.0944.888.8937.02
Net income per share
-1.18K-625.25-603.06-505.0762.48
Operating cash flow per share
-260.4-236.52-387.4-71.39-229.85
Free cash flow per share
-544.98-250.38-399.23-199.48-255.33
Cash per share
671.252.3K1.96K2.17K1.56K
Book value per share
8.45K8.81K7.86K7.1K7.16K
Tangible book value per share
8.53K8.88K7.84K7.09K7.11K
Share holders equity per share
8.45K8.81K7.86K7.1K7.16K
Interest debt per share
2.6K1.97K1.86K1.97K1.66K
Market cap
466.44B471.58B416.32B366.42B428.18B
Enterprise value
532.58B463.07B431.67B444.77B489.57B
P/E ratio
-3.02-4.93-4.23-4.3841.34
Price to sales ratio
202.09681.56227.3994.3279.01
POCF ratio
-54.8-52.13-26.33-123.82-44.94
PFCF ratio
-26.18-49.24-25.55-44.32-40.46
P/B Ratio
1.691.41.31.241.44
PTB ratio
1.691.41.31.241.44
EV to sales
230.74669.26235.681.21K319.02
Enterprise value over EBITDA
-43.81-45.71-40.15-30.51-342.57
EV to operating cash flow
-62.57-51.19-27.3-150.3-51.39
EV to free cash flow
-29.9-48.36-26.49-53.79-46.26
Earnings yield
-0.08-0.05-0.06-0.060.01
Free cash flow yield
-0.04-0.02-0.04-0.02-0.02
Debt to equity
0.30.220.230.270.23
Debt to assets
0.220.170.180.210.18
Net debt to EBITDA
-5.440.84-1.43-5.37-42.96
Current ratio
0.661.751.661.711.69
Interest coverage
-13.48-11.74-12.36-17.77-2.03
Income quality
0.220.380.640.14-3.68
Dividend Yield
0.010.160.0200
Payout ratio
-0.14-3.1-0.2700.01
Sales general and administrative to revenue
0.220.750.241.310.32
Research and developement to revenue
3.5410.044.2720.310.83
Intangibles to total assets
0.010000.01
Capex to operating cash flow
1.090.060.031.790.11
Capex to revenue
-4.03-0.77-0.26-14.41-0.69
Capex to depreciation
-6.97-0.42-0.39-4.33-0.8
Stock based compensation to revenue
0.371.270.481.770.36
Graham number
14.99K11.13K10.32K8.98K3.17K
ROIC
-0.04-0.03-0.03-0.050
Return on tangible assets
-0.1-0.05-0.06-0.050.01
Graham Net
-2.1K179.5975.89219.38-4.28
Working capital
-26.55B52.13B50.39B51.07B37.63B
Tangible asset value
278.85B339.63B319.94B293.72B294.89B
Net current asset value
-55.49B23.81B30.99B25.96B12.48B
Invested capital
0.30.220.230.270.23
Average receivables
14.64B14.99B16.01B16.42B16.65B
Average payables
00.50.500
Average inventory
6.01B12.06B11.88B10.61B6.68B
Days sales outstanding
584.761.95K837.53.86K1.03K
Days payables outstanding
00000
Days of inventory on hand
385.5685.69386.08531.81139.85
Receivables turnover
0.150.050.110.020.09
Payables turnover
01.59B000
Inventory turnover
0.230.130.230.170.64
ROE
-0.14-0.07-0.08-0.070.01
Capex per share
-284.58-13.86-11.83-128.09-25.49

095700.KQ Frequently Asked Questions

What is Genexine, Inc. stock symbol ?

Genexine, Inc. is a KR stock and trading under the symbol 095700.KQ

What is Genexine, Inc. stock quote today ?

Genexine, Inc. stock price is $9040 today.

Is Genexine, Inc. stock public?

Yes, Genexine, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks